Abstract:OBJECTIVE:To explore the clinical characteristics, therapeutic and clinical significance for RET proto-oncogene screening in a pedigree with familial medullary thyroid carcinoma.METHODS:Comprehensive medical history was obtained from 19 members in a 4-generate southern Chinese family. Systemic clinical investigations including biochemical testing, imaging examinations and germline RET screening.RESULTS:RET screening showed heterozygous missense mutations of TGC to TAC at codon 618 on exon 10 in 8 cases (p.C618Y) completely consistent with the clinical manifestations. The clinical data of 7 patients with medullary thyroid carcinoma (MTC) and 2 carriers of asymptomatic RET mutation from were analyzed. Single/bilateral multi-centric MTC with lymph node metastases was confirmed in 6 cases by histopathology and 1 case by clinical examination. There were 1 male and 6 females with an initial mean diagnostic age was 49.6 years (range: 24 - 78). All had palpable neck masses. And the mean maximum diameter of MTC was 2.6 cm (range 1.4 - 4.4). Seven patients underwent thyroidectomy except a 78-year-old female patient: right total and left subtotal thyroidectomy (n = 1), right total thyroidectomy (previous left total thyroidectomy for benign mass) (n = 1) and total thyroidectomy (n = 4) were performed. All procedures were accompanied by at least bilateral level VI lymph node dissection and/or with modified single/bilateral neck dissection. After the first operation, 6 patients still presented a high value of calcitonin: 1 patient died of metastasis 64 months postoperatively; 3 patients underwent reoperation at 6 months after initial operation, the calcitonin levels dropped to normal in 2/3 cases and stayed higher in 1 case; another two cases presented bilateral thyroid gland residua, local lymph node enlargement on imaging examination and elevated levels of calcitonin at 214 and 60 months postoperation respectively. However, 1/2 asymptomatic with elevated pre-operative calcitonin subjects underwent total thyroidectomy and histopathological examination showed bilateral C cell hyperplasia. The other carriers, without surgery, with normal neck images, close monitoring and a 10-month follow-up, still presented undetectable calcitonin.CONCLUSIONS:Based on family survey, integrated RET screening and serum levels of calcitonin facilitate an early diagnosis and normalize surgery to improve the prognosis. For asymptomatic RET mutation carriers, their levels of calcitonin shall guide the individualized regimen of prophylactic thyroidectomy or strict monitoring and follow-ups.

RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

The Rare Intracellular RET Mutation P.s891a in a Chinese Han Family with Familial Medullary Thyroid Carcinoma

Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma

[Clinical Diagnosis and Treatment of Familial Medullary Thyroid Carcinoma Caused by a P.c618y RET Proto-Oncogene Mutation in a Chinese Pedigree].

The Rare RET Mutation Y606C in a Chinese Family with Familial Medullary Thyroid Carci-Noma

Screening of RET Gene Mutations in Chinese Patients with Medullary Thyroid Carcinoma and Their Relatives

RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2a/familial Medullary Thyroid Carcinoma Family.

Mutation Analysis of the OSMR Gene in Two Chinese Families with Familial Primary Cutaneous Amyloidosis

Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families.

Rare RET Variant P.d707e in a Chinese Pedigree with Hereditary Medullary Thyroid Carcinoma.

Mutation Analysis of the OSMR Gene in a Family with Familial Primary Cutaneous Amyloidosis

Multiple Endocrine Neoplasia Type 2A Caused by a P.c618r RET Proto-Oncogene Mutation in a Chinese Pedigree

Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation

RET c.1901G>A and Novel SLC12A3 Mutations in Familial Pheochromocytomas

[A Case Report and Pedigree Study of a Single Point Mutation in RET Proto-Oncogene and Type 2B Multiple Endocrine Neoplasia].

C634Y mutation in RET -induced multiple endocrine neoplasia type 2A: A case report

A New C.1845a→t of Oncostatin M Receptor-Β Mutation and Slightly Enhanced Oncostatin M Receptor-Β Expression in a Chinese Family with Primary Localized Cutaneous Amyloidosis

Mutation of the ret proto-oncogene in two Chinese families with multiple endocrine neoplasia type 2A(MEN2A).

Familial Multinodular Goiter Syndrome with Papillary Thyroid Carcinomas: Mutational Analysis of the Associated Genes in 5 Cases from 1 Chinese Family.

DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)]